Search details
1.
Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 24(7): 798-810, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37290468
2.
Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study.
BMC Med
; 21(1): 464, 2023 11 27.
Article
in English
| MEDLINE | ID: mdl-38012705
3.
Nasopharyngeal necrosis contributes to overall survival in nasopharyngeal carcinoma without distant metastasis: a comprehensive nomogram model.
Eur Radiol
; 33(5): 3682-3692, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36735041
4.
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT.
Eur J Nucl Med Mol Imaging
; 48(8): 2586-2598, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33420610
5.
Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
Eur Radiol
; 31(7): 5222-5233, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33416977
6.
Efficacy of controlled-release oxycodone for reducing pain due to oral mucositis in nasopharyngeal carcinoma patients treated with concurrent chemoradiotherapy: a prospective clinical trial.
Support Care Cancer
; 27(10): 3759-3767, 2019 Oct.
Article
in English
| MEDLINE | ID: mdl-30712098
7.
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.
Lancet Oncol
; 19(4): 461-473, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29501366
8.
The elevated pretreatment platelet-to-lymphocyte ratio predicts poor outcome in nasopharyngeal carcinoma patients.
Tumour Biol
; 36(10): 7775-87, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-25944165
9.
Expression of Aurora-B and FOXM1 predict poor survival in patients with nasopharyngeal carcinoma.
Strahlenther Onkol
; 191(8): 649-55, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-25986250
10.
The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy.
BMC Cancer
; 15: 977, 2015 Dec 16.
Article
in English
| MEDLINE | ID: mdl-26675209
11.
Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma.
Chin J Cancer
; 34(6): 237-46, 2015 Jun 10.
Article
in English
| MEDLINE | ID: mdl-26067059
12.
A new T classification based on masticator space involvement in nasopharyngeal carcinoma: a study of 742 cases with magnetic resonance imaging.
BMC Cancer
; 14: 653, 2014 Sep 04.
Article
in English
| MEDLINE | ID: mdl-25189623
13.
Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma.
Radiother Oncol
; 191: 110051, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38135184
14.
The independent, unfavorable prognostic factors endothelin A receptor and chemokine receptor 4 have a close relationship in promoting the motility of nasopharyngeal carcinoma cells via the activation of AKT and MAPK pathways.
J Transl Med
; 11: 203, 2013 Aug 29.
Article
in English
| MEDLINE | ID: mdl-23987636
15.
Randomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
Chin J Cancer
; 32(9): 502-11, 2013 Sep.
Article
in English
| MEDLINE | ID: mdl-23816561
16.
The map of bone metastasis in nasopharyngeal carcinoma: A real-world study.
Cancer Med
; 12(17): 17660-17670, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37563937
17.
Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA-IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trial.
Lancet Reg Health West Pac
; 40: 100895, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37691885
18.
A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patients.
Eur J Cancer
; 191: 112965, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37540921
19.
Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial.
Nat Commun
; 14(1): 4893, 2023 08 14.
Article
in English
| MEDLINE | ID: mdl-37580352
20.
Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial.
Eur J Cancer
; 194: 113336, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37801967